Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 674 | 666 | 681 | 682 | 674 |
| Gross Profit | 674 | 666 | 681 | 682 | 674 |
| Operating Expenses | 4,465 | 5,874 | 10,421 | 8,871 | 12,091 |
| Operating Income | -3,791 | -5,208 | -9,740 | -8,189 | -11,417 |
| Other Income | 2,478 | 1,597 | 1,004 | 1,036 | 350 |
| Pre-tax Income | -1,313 | -3,611 | -8,736 | -7,153 | -11,067 |
| Income Tax | N/A | N/A | N/A | 100 | N/A |
| Net Income Continuous | -1,313 | -3,611 | -8,736 | -7,253 | -11,067 |
| Minority Interests | -119 | N/A | -476 | -193 | -534 |
| Net Income | $-1,194 | $-3,611 | $-8,260 | $-7,060 | $-10,533 |
| EPS Basic Total Ops | -0.03 | -0.08 | -0.22 | -0.18 | -0.27 |
| EPS Basic Continuous Ops | -0.03 | -0.09 | -0.22 | -0.19 | -0.29 |
| EPS Diluted Total Ops | -0.03 | -0.08 | -0.22 | -0.18 | -0.27 |
| EPS Diluted Continuous Ops | -0.03 | -0.09 | -0.22 | -0.19 | -0.29 |
| EBITDA(a) | $-3,739 | $-5,171 | $-9,723 | $-8,174 | $-11,402 |